Home Featured 2

Featured 2

Featured posts

Most popular

Dr. Jamie E. Chaft Discusses Emerging Data on Induction Immunotherapy for NSCLC

lungcanc

Dr. Richard Pazdur Discusses Project Facilitate and the Expanded-Access Program

Telehealth: Bridging the Digital Divide Is Still a Work In Progress

PCI Decreases the Risk of Brain Metastases in Patients with Locally Advanced NSCLC

Time to End the Debate on Genomic Testing in NSCLC

JAVELIN Lung 200: Potential Reasons for Avelumab’s Failure to Provide OS...

lungcanc

On the Backs of Specialists: LDCT Screening Has Heightened the Importance...

lungcanc

An Interview with Dr. Federico Cappuzzo: Checkpoint Inhibitors Have Replaced Old...

lungcanc

Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data

lungcanc

Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication

lungcanc

2019 IASLC Best of the World Lung Cancer Conference Results in...

lungcanc

A Cloud-Based Computerized System for the Korean Lung Cancer Screening Project

lungcanc

Key Findings from the CAR T-Cell Study Presented at the 2019...

lungcanc

Stage IIIA NSCLC: A Review of Recent and Ongoing Trials Trial

lungcanc

Lung Cancer Global Mortality Projections Skyrocket for Women

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib